From: Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache
Variables | Pre-treatment (Ketorolac) | Pre-treatment (Sumatriptan) | Post-treatment (Ketorolac) | Post-treatment (Sumatriptan) |
---|---|---|---|---|
Palpitation | 100% | 94.1% | 100% | 100% |
Flushing | 100% | 100% | 100% | 100% |
Heat sensation | 100% | 100% | 100% | 100% |
Nausea | 0% | 0% | 0% | 0% |
Neck stiffness | 11.8% | 11.7% | 17.7% | 17.7% |
Difficulty concentrating | 5.9% | 5.9% | 23.5% | 17.8% |
Fatigue | 23.5% | 17.7% | 23.5% | 23.5% |
Thirst | 17.7% | 11.8% | 11.8% | 23.5% |
Facial puffiness | 41.2% | 35.3% | 41.2% | 17.7% |